Introduction

In the treatment of arch aortic lesions, cross-border cooperation and technical exchange play a crucial role. In recent years, with the continuous innovation of vascular surgery technology, medical experts in Asia have actively responded to the call of international cooperation and issued the "Asian Expert Consensus on the Treatment of Aortic Lesions Involving the Arch by Hybridization Technology". This consensus not only provides standardized guidance for treatment in the Asian region, but also lays the foundation for technological advancement and collaboration in the field of vascular surgery worldwide.

The Asian Expert Consensus was developed by well-known experts in the field of vascular surgery from China, Japan, South Korea, India and other countries. This consensus summarizes the experience of many countries in the treatment of arch aortic lesions, and proposes the clinical application criteria of hybridization technology in the treatment of arch aortic lesions. Through the analysis of medical resources in different countries and regions, experts have put forward more personalized treatment recommendations for the special situation in Asia.

The consensus emphasizes that hybridization technology has a wide range of adaptability in the treatment of arch aortic lesions, especially for patients with multiple risk factors (such as advanced age, hypertension, diabetes, etc.). In the consensus, experts mentioned that although hybridization technology has been recognized globally, in different countries and regions, the differences in patients' conditions and medical resources make the formulation of treatment plans need to be more carefully considered and localized.

In addition, the consensus also put forward the need to strengthen international academic exchanges and technical cooperation. Through mutual visits, exchanges and collaborative research, vascular surgeons from Asian countries can not only share each other's experiences, but also jointly promote the global development of vascular surgery technology. For example, in some regions, the successful use of hybridization technology has become a model for global medical institution cooperation, with experts from other countries learning and sharing experiences to apply the technology to the treatment of patients in their own countries.

The Asian Expert Consensus on the Treatment of Aortic Lesions Involving the Arch by Hybridization Technology is an important academic breakthrough in the field of vascular surgery in Asia. It provides a scientific basis for the treatment of arch aortic lesions and creates new opportunities for medical cooperation in Asia and around the world. With the continuous development of technology and the deepening of international cooperation, hybridization technology is expected to be promoted globally to benefit more patients.